Tech Company Financing Transactions

RheumaGen Funding Round

RheumaGen closed a $15 million Series A funding round on 1/10/2025. Investors included SPRIM Global Investments, William Taylor Nominees and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Undisclosed
Aurora, CO Undisclosed
USA

Phone

Undisclosed

Website

www.rheumagen.com

Email Address

Not Recorded

Overview

RheumaGen, an Aurora, CO-based cell and gene therapy company.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Richard Freed

        

Chief Scientific Officer

Brian Freed

        

Browse more venture capital transactions:

Prev: 1/9/2025: RyboDyn venture capital transaction
Next: 1/10/2025: Pipe17 venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary